Cabergoline-induced NDFIP1 upregulation in pituitary neuroendocrine tumor cells activates mTOR signaling and contributes to cabergoline resistance. [PDF]
J NeurooncolGu W, Zhang W, Wu Z, Cai Y.
europepmc +1 more source
Increased Cardiometabolic Risk in Men with Hypoprolactinemia: A Pilot Study. [PDF]
BiomoleculesKrysiak R +3 more
europepmc +1 more source
Network based approach for drug target identification in early onset Parkinson's disease. [PDF]
Sci RepDey A +3 more
europepmc +1 more source
Efficacy of Metformin-Cabergoline Compared to Metformin Monotherapy for Management of PCOS With Hyperprolactinemia: A Systematic Review and Meta-analysis. [PDF]
Clin Med Insights Endocrinol DiabetesKumar A +11 more
europepmc +1 more source
Reframing the Paradigm: A Nuanced Approach to Prolactinoma Management. [PDF]
Endocrinol Metab (Seoul)Kim JH.
europepmc +1 more source
Resistant PRL-secreting PitNET associated with breast carcinoma: a case report and literature review. [PDF]
Int Cancer Conf JDumitriu-Stan RI +5 more
europepmc +1 more source
A Narrative Review of Surgery for Prolactinomas: Considerations and Controversies. [PDF]
J Clin MedMann JA +3 more
europepmc +1 more source
A Peculiar Case of Cabergoline Response to a Non-functioning Cystic Pituitary Adenoma in a Young Adult Male. [PDF]
CureusRahman A, Piasecki J, Rogers P, Koo D.
europepmc +1 more source
Lactation anaphylaxis complicated by reversible cardiac dysfunction in a multiparous woman with previous breastfeeding experience. [PDF]
Obstet MedAl-Tikriti S +4 more
europepmc +1 more source
Medical Treatment of Cushing's Syndrome. [PDF]
Endocrinol Metab (Seoul)Guignat L, Bertherat J.
europepmc +1 more source